Cross-border securities financing is not one-size-fits-all. Each jurisdiction brings its own regulatory framework, foreign exchange controls, and structural requirements. For shareholders of listed companies in Asia, understanding these differences is critical before approaching a lender.
Korea — Non-Recourse Loans & Block Trades
The Korean market operates under a distinct regulatory and execution framework. Medcorp's Korea program covers both non-recourse stock loans for KOSPI and KOSDAQ-listed equities, and block trade facilitation for larger positions. All transactions follow mandatory procedures designed to ensure regulatory compliance and market integrity.
India — Offshore SPV Structure
India presents a highly regulated environment for cross-border securities financing. Foreign exchange regulations, remittance controls, and restrictions on onshore leverage mean that standard global structures cannot be applied directly. Medcorp's India program uses a standardised offshore structure — involving an Indian SPV, FDI framework transfer, and offshore brokerage account — to navigate these constraints compliantly.
"In India, execution certainty requires a tightly governed, standardised approach. Flexibility must give way to compliance."
Indonesia — IDX-Listed Equity Financing
Medcorp operates a dedicated Indonesia market program for non-recourse financing of IDX-listed equities. The program follows strict eligibility requirements — including minimum market capitalisation, public float thresholds, and daily trading volume history — with USD-denominated loans structured in tranches aligned to market liquidity.
Each of these programs has been designed from the ground up for its specific jurisdiction. If you hold listed shares in any of these markets and want to explore financing options, contact our team for a confidential assessment.
Ready to explore your financing options?
Our team responds within 1–2 working days — completely confidential.
Request Funding →